SignatureDx is a team of experts from diverse backgrounds.

Our team rocks.

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Our Team

1516270660303

Dave Colaizzi

CEO, Co-Founder

Dave Colaizzi is the Chief Executive Officer and Co-Founder at SignatureDx, a biotechnology company created with a vision of identifying biomarkers for early-stage disease detection so that treatment can help improve patient outcomes.
1516270660303

Dave Colaizzi

CEO, Co-Founder

Dave Colaizzi is the Chief Executive Officer and Co-Founder at SignatureDx, a biotechnology company created with a vision of identifying biomarkers for early-stage disease detection so that treatment can help improve patient outcomes.
1516270660303

Dave Colaizzi

CEO, Co-Founder

Dave Colaizzi is the Chief Executive Officer and Co-Founder at SignatureDx, a biotechnology company created with a vision of identifying biomarkers for early-stage disease detection so that treatment can help improve patient outcomes.
1516270660303

Dave Colaizzi

CEO, Co-Founder

Dave Colaizzi is the Chief Executive Officer and Co-Founder at SignatureDx, a biotechnology company created with a vision of identifying biomarkers for early-stage disease detection so that treatment can help improve patient outcomes.